delphinidin has been researched along with dinoprostone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bode, AM; Dong, Z; Heo, YS; Hwang, MK; Jung, SK; Kang, NJ; Kim, JE; Kwon, JY; Lee, HJ; Lee, KW | 1 |
Chen, D; Haqqi, TM; Haseeb, A | 1 |
2 other study(ies) available for delphinidin and dinoprostone
Article | Year |
---|---|
Delphinidin suppresses ultraviolet B-induced cyclooxygenases-2 expression through inhibition of MAPKK4 and PI-3 kinase.
Topics: Animals; Anthocyanins; Cells, Cultured; Cyclooxygenase 2; Dietary Carbohydrates; Dinoprostone; Enzyme Activation; Epidermis; Female; MAP Kinase Kinase 4; Mice; Mice, Inbred ICR; NF-kappa B; Phosphoinositide-3 Kinase Inhibitors; Skin Neoplasms; Transcription Factor AP-1; Ultraviolet Rays; Up-Regulation | 2009 |
Delphinidin inhibits IL-1β-induced activation of NF-κB by modulating the phosphorylation of IRAK-1(Ser376) in human articular chondrocytes.
Topics: Anthocyanins; Cartilage, Articular; Chondrocytes; Cyclooxygenase 2; Dinoprostone; Humans; Interleukin-1 Receptor-Associated Kinases; Interleukin-1beta; NF-kappa B; Nitriles; Phosphorylation; Receptors, Interleukin-1; Signal Transduction; Sulfones; Tumor Necrosis Factor-alpha | 2013 |